Targeted neoepitope vectors and methods therefor
US11779637B2 · kind B2 · utility
1Cited by
8References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 23, 2018 |
| Grant date | Oct 10, 2023 |
| Priority date | — |
| Expiry date | Apr 23, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Systems and methods are presented that allow for selection of tumor neoepitopes that are then used to generate recombinant nucleic acids that encode one or more polytopes that are optimized for proper trafficking and processing. In preferred methods, the polytopes are encoded in a plasmid and/or a viral expression system for use as a therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.